Biology of oral premalignant lesions: Concepts and implications for chemoprevention

European Journal of Cancer Prevention

Volumn 5, Issue SUPPL. 2, 1996, Pages 87-93

  Papadimitrakopoulou, V A ^a   Hong, W K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; ISOTRETINOIN; N (4 HYDROXYCARBOPHENYL)RETINAMIDE; RETINOID; RETINOL; UNCLASSIFIED DRUG;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ANTICARCINOGENIC AGENTS; CHROMOSOME ABERRATIONS; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH NEOPLASMS; PHENOTYPE; PRECANCEROUS CONDITIONS; PROTO-ONCOGENES; RETINOIDS;

EID: 0030504867     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199612002-00013     Document Type: Conference Paper

References (67)

1. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54:1617-1621.
2. Benner SE, Lippman SM, Wargovich MJ, et al. (1994) Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral premalignancy. Int J Cancer 59:457-459.
3. Bollag W, Peck R (1993) Modulation of cell proliferation and differentiation by retinoids, cytokines, and their combination: experimental and clinical aspects. In Retinoids: Progress in Research and Clinical Applications. Edited by Livera MA, Packer L. New York, NY: Dekker; pp 311-328.
4. Boone C, Kelloff GJ, Malone WE (1990) Identification of candidate cancer chemoprevention agents and their evaluation in animal models and human clinical trials:a review. Cancer Res 50:2-9.
5. Brennan JA, Boyle JO, Koch WM, et al. (1995) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332:712-717.
6. Brennan JA, Mao L, Hruban RH, et al. (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435.
7. Califano J, van der Riet P, Westra W, et al. (1996) Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2488-2492.
8. Chiesa F, Tradati N, Marazza M, et al. (1992) Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretnide(4-HPR):preliminary results. Eur J Cancer 28:97-102.
9. Cooper JS, Pajak TF, Rubin P, et al. (1989) Second malignancies in patients who have head and neck cancers: Incidence,effect on survival and implications for chemoprevention based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449-456.
10. Dimery I, Shirinian M, Heyne K, et al. (1992) Reduction in toxicity of high dose 13-cRA with alpha-tocopherol (AT) [abstract]. Proc Am Soc Clin Oncol 11:145.
11. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328:184-193.
12. Einhorn J, Wersall J (1967) Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 20:2189-2193.
13. Farber E (1984) The multistep nature of cancer development. Cancer Res 44:4217-4223.
14. Gudas LJ, Sporn MB, Roberts AB (1994) Cellular Biology and Biochemistry of the Retinoids. In The Retinoids: Biology, Chemistry, and Medicine. Edited by Sporn MB, Roberts AB, Goodman DS. New York: Raven Press; pp 443-520.
15. Han J, Jiao L, Lu Y, Sun Z, Gu QM, Scanlon KJ (1990) Evaluation of N-4-(hydroxycarbophenyl)retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 4:153-160.
16. Healy GB, Gelber RD, Trowbridge AL, et al. (1988) Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. results of a multicenter randomized clinical trial. N Engl J Med 319:401-407.
17. Hinds PH, Dowdy SF, Eaton EN, Arnold A, Weinberg RA (1994) Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713.
18. Hong WK, Lippman SM, Hittelman WN, Lotan R (1995) Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res 1:677-686.
19. Hong WK, Endicott J, Itri L, et al. (1986) 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505.
20. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
21. Izzo J, Papadimitrakopoulou V, Lee JS, et al. (1996) Role of Cyclin D1 in the multistep tumorigenesis process of head and neck squamous cell carcinomas (HNSCC) [abstract]. Proc Am Assoc Cancer Res 37:3687.
22. Jetten AM, Kim JS, Sacks PG, et al. (1990) Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. Int J Cancer 45: 195-202.
23. Kamb A, Gruis NA, Weaverfeldhaus J, Liu QY, Harshman K (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
24. Lammie GA, Peters G (1991) Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420.
25. Lee JS, Kim SY, Hong WK, Lippman SM, Ro JY, Gay ML, Hittelman WN (1993) Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst 85: 1951-1954.
26. Leid M, Kastner P, Chambon P (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17:427-433.
27. Lippman SM, Shin DM, Lee JJ, et al. (1995) p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res 55:16-19.
28. Lippman SM, Kavanagh JJ, Paredees-Espinoza M, et al. (1992) 13-cRA plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241-246.
29. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK (1990) Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 82:555-560.
30. Lotan R, Xu X-C, Lippman SM, et al. (1995) Suppression of retinoic acid receptor in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 332:1405-1410.
31. Lippman SM, Batsakis JG, Toth BB, et al. (1993) Comparison of low-dose isotretinoin with β-carotene to prevent oral carcinogenesis. N Engl J Med 328:15-20.
32. Lotan R (1993) Retinoids and squamous cell differentiation. In Retinoids in Oncology. Edited by Hong WK, Lotan R. New York: Marcel Dekker; pp 43-72.
33. Maestro R, Gasparotto D, Vuksavljevic T, Barzan L, Sulfaro S, Boiocchi M (1993) Three discrete regions of deletion in head and neck cancers. Cancer Res 53:5775-5779.
34. Maestro R, Dolcetti R, Gasparotto D, et al. (1992) High frequency of p53 alterations associated with protein overexpression in human squamous-cell carcinoma of the larynx. Oncogene 7:1159-1166.
35. Mao L, Lee JS, Fan YH, et al. (1996) Frequent micro-satellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Med 2:682-265.
36. Mashberg AL (1977) Erythroplasia versus leukoplakia in the diagnosis of early asymptomatic oral squamous carcinoma. N Engl J Med 297:109-110.
37. Merlo A, Herman JG, Mao L, et al. (1995) 5′ CpG island methylation is associated with transciptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686-692.
38. Meyskens FL Jr. (1990) Coming of age: the chemoprevention of cancer. N Engl J Med 323:825-827.
39. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975-978.
40. Motokura T, Bloom T, Kim HG, et al. (1991) A novel cyclin encoded by BCL-1-linked candidate oncogene. Nature (Lond) 350:512-515.
41. Nawroz H, van der Riet P, Hruban RH, Koch WM, Ruppert JM, Sidransky D (1994) Allelotype of head and neck squamous cell carcinoma. Cancer Res 54:1152-1155.
42. Nees M, Homann N, Discher H, et al. (1993) Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients:a possible molecular basis for the development of multiple tumors. Cancer Res 53:4189-4196.
43. Papadimitrakopoulou V, Lippman SM, Lee JS, et al. (1996) Long term follow-up of low-dose isotretinoin (13-cRA) versus beta carotene to prevent oral carcinogenesis [abstract]. Proc Am Soc Clin Oncol 15:340.
44. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics 1996. CA Cancer J Clin 46:8-9.
45. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197.
46. Pinkel D, Straume T, Gray JW (1986) Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
47. Saffiotti V, Montesano R, Sellakumar A, Borg S (1967) Experimental cancer of the lung: inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumours. Cancer 20:857-864.
48. Sheng ZM, Barrois M, Klijanienko J, Micheau C, Richard JM, Rio G (1990) Analysis of the c-Ha-ras-1 gene for deletion, mutaton, amplification and expresion in lymph node metastases of human head and neck cancer. Br J Cancer 62:398-404.
49. Shin DM, Kim J, Ro JY, et al. (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:321-326.
50. Shin DM, Ro JY, Hong WK, Hittelman WN (1994) Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:3153-3159.
51. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN (1993) Sequential upregulation of proliferating cell nuclear antigen in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 85:971-978.
52. Shklar G, Schwartz J, Grau D, et al. (1980) Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg 50:45-52.
53. Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 53:563-568.
54. Sklar G (1986) Oral leukoplakia. N Engl J Med 315: 1544-1546.
55. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6:963-968.
56. Soder AI, Hopman AHN, Ramaekers FCS, Conradt C, Bosch FX (1995) Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res 55:5030-5037.
57. Somers KD, Merrick MA, Lopez ME, et al. (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997-6000.
58. Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010-1013.
59. Sporn MB, Dunlop NM, Newton DL, et al. (1976) Prevention of chemical carcinogenesis by vitamin A and its synergistic analogs (retinoids). Fed Proc 35:1332-1338.
60. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Krishnan Nair M (1988) Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 40: 93-101.
61. Stich HF (1987) Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials. J Nutr Growth Cancer 4:9-18.
62. Van Dyke DL, Worsham MJ, Benninger MS, et al. (1994) Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9:192-206.
63. Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN (1993) Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 53:2784-2883.
64. Wu CL, Sloan P, Read AP, Harris R, Thakker N (1994) Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 54:6484-6488.
65. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R (1988) Differential expression of nuclear retinoid receptors in normal,premalignant and malignant head and neck tissues. Cancer Res 54:3580-3587.
66. Zelen M (1988) Are primary cancer prevention trials feasible? J Natl Cancer Inst 80:1442-1444.
67. Zhang SY, Klein-Szanto AJP, Sauter ER, et al. (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54:5050-5053.